Essilorluxottica Sa has released a press release.
EssilorLuxottica: Déclaration de transactions sur actions propres
Earlier from Essilorluxottica Sa
- EssilorLuxottica: 24-Month U.S. Clinical Trial Results Supporting FDA De Novo Market Authorization of Essilor Stellest Lenses* Published in JAMA Ophthalmology
- EssilorLuxottica: Publication of the 2026 Interim Financial Report